AKN-028

· Akinion Pharmaceuticals AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AKN-028, covering 2016-03-25 to 2016-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia [Phase 1, Phase 2]